0
0

Teleabortion Prevention Act of 2019

11/1/2022, 4:47 AM

Congressional Summary of HR 4935

Teleabortion Prevention Act of 2019

This bill restricts the use of telehealth for chemical abortions (also known as medication abortions).

Specifically, it requires a provider who dispenses or prescribes medication for a chemical abortion to physically examine the patient, be physically present at the location of the chemical abortion, and schedule a follow-up visit. The bill provides an exception for a chemical abortion that is necessary to save the life of a mother whose life is endangered by a physical disorder, illness, injury, or condition.

The bill establishes criminal penalties—a fine, a prison term of up to two years, or both—for a provider who does not comply with the requirements.

A patient who undergoes a chemical abortion may not be prosecuted.

Current Status of Bill HR 4935

Bill HR 4935 is currently in the status of Bill Introduced since October 30, 2019. Bill HR 4935 was introduced during Congress 116 and was introduced to the House on October 30, 2019.  Bill HR 4935's most recent activity was Referred to the Subcommittee on Crime, Terrorism, and Homeland Security. as of December 18, 2019

Bipartisan Support of Bill HR 4935

Total Number of Sponsors
1
Democrat Sponsors
0
Republican Sponsors
1
Unaffiliated Sponsors
0
Total Number of Cosponsors
23
Democrat Cosponsors
0
Republican Cosponsors
23
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill HR 4935

Primary Policy Focus

Crime and Law Enforcement

Potential Impact Areas

- Abortion
- Civil actions and liability
- Health personnel
- Health technology, devices, supplies
- Medical ethics
- Medical tests and diagnostic methods

Alternate Title(s) of Bill HR 4935

Teleabortion Prevention Act of 2019
To prohibit chemical abortions performed without the presence of a healthcare provider, and for other purposes.
Teleabortion Prevention Act of 2019

Comments